Aquestive Therapeutics, Inc.
AQST- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001398733
In the last 90 days, Aquestive Therapeutics, Inc. insiders filed 0 open-market purchases and 4 sales; 185 institutions reported holding it in 13F filings for Q2 2026, worth $299.5M in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Aquestive Therapeutics, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 46
- 0 vs. Q2 2022
- Shares held
- 15.9M
- −746.0K (−4.5%) vs. Q2 2022
- Total value
- $18.6M
- +$7.88M (+73.7%) vs. Q2 2022
- New holders
- 6
- 11 more added
- Sold out
- 6
- 14 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AQST on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 185 | $299.5M |
| Q1 2026 | 180 | $298.6M |
| Q4 2025 | 179 | $467.0M |
| Q3 2025 | 152 | $369.3M |
| Q2 2025 | 117 | $157.6M |
| Q1 2025 | 121 | $127.8M |
| Q4 2024 | 114 | $154.4M |
| Q3 2024 | 117 | $232.4M |
| Q2 2024 | 98 | $110.7M |
| Q1 2024 | 97 | $176.8M |
| Q4 2023 | 57 | $48.1M |
| Q3 2023 | 48 | $21.5M |
| Q2 2023 | 54 | $31.5M |
| Q1 2023 | 35 | $17.0M |
| Q4 2022 | 37 | $13.5M |
| Q3 2022 | 46 | $18.6M |
| Q2 2022 | 46 | $10.7M |
| Q1 2022 | 51 | $40.6M |
| Q4 2021 | 52 | $62.9M |
| Q3 2021 | 46 | $64.4M |
| Q2 2021 | 60 | $62.0M |
| Q1 2021 | 64 | $86.4M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Aquestive Therapeutics, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bratton Capital Management, L.P. | 9,810,958 | $11.5M | 100.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,181,540 | $1.38M | 0.00% | −100,966−7.9% | Reduced |
| Renaissance Technologies LLC | 900,800 | $1.05M | 0.00% | −325,600−26.5% | Reduced |
| Vahanian & Associates Financial Planning Inc. | 695,258 | $813.0K | 2.80% | +138,500+24.9% | Added |
| Millennium Management LLC | 475,871 | $557.0K | 0.00% | −632,893−57.1% | Reduced |
| Bracebridge Capital, LLC | 428,571 | $501.0K | 0.18% | 00.0% | Unchanged |
| Schonfeld Strategic Advisors LLC | 406,700 | $475.0K | 0.00% | +325,600+401.5% | Added |
| BlackRock Inc. | 373,878 | $437.0K | 0.00% | +2,162+0.6% | Added |
| Geode Capital Management, LLC | 365,899 | $428.0K | 0.00% | +121,537+49.7% | Added |
| Latash Investments, LLC | 243,134 | $284.0K | 0.23% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 142,956 | $167.0K | 0.00% | −61,400−30.0% | Reduced |
| HighTower Advisors, LLC | 130,305 | $152.0K | 0.00% | +130,305 | New |
| State Street Corp | 96,037 | $112.0K | 0.00% | 00.0% | Unchanged |
| Man Group plc | 89,900 | $105.0K | 0.00% | – | – |
| Northern Trust Corp | 62,090 | $73.0K | 0.00% | +14,541+30.6% | Added |
| Beacon Pointe Advisors, LLC | 60,000 | $70.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 39,900 | $47.0K | 0.00% | −8,000−16.7% | Reduced |
| Tower Research Capital LLC (TRC) | 34,875 | $41.0K | 0.00% | −3,264−8.6% | Reduced |
| Morgan Stanley | 33,381 | $39.0K | 0.00% | +13,517+68.0% | Added |
| Group One Trading, L.P. | 29,942 | $35.0K | 0.00% | −14,357−32.4% | Reduced |
| Financial Advocates Investment Management | 27,000 | $32.0K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 27,704 | $32.0K | 0.00% | +13,545+95.7% | Added |
| Cresset Asset Management, LLC | 26,000 | $30.0K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 23,850 | $28.0K | 0.00% | +23,850 | New |
| Wells Fargo & Company | 21,366 | $25.0K | 0.00% | −928−4.2% | Reduced |
| Mackenzie Financial Corp | 20,318 | $24.0K | 0.00% | −41,381−67.1% | Reduced |
| Royal Bank of Canada | 20,087 | $23.0K | 0.00% | +20,087 | New |
| Citadel Advisors LLC | 18,063 | $21.0K | 0.00% | −53,932−74.9% | Reduced |
| Bank of Montreal | 17,730 | $21.0K | 0.00% | +531+3.1% | Added |
| Bank of New York Mellon Corp | 14,853 | $17.0K | 0.00% | 00.0% | Unchanged |
| Gsa Capital Partners LLP | 13,704 | $16.0K | 0.00% | +13,704 | New |
| D.B. Root & Company, LLC | 12,500 | $14.0K | 0.01% | 00.0% | Unchanged |
| Running Point Capital Advisors, LLC | 10,000 | $12.0K | 0.01% | 00.0% | Unchanged |
| Bayesian Capital Management, LP | 10,235 | $12.0K | 0.00% | +10,235 | New |
| UBS Group AG | 9,068 | $11.0K | 0.00% | +8,653+2,085.1% | Added |
| Quantbot Technologies LP | 3,751 | $4.00K | 0.00% | 00.0% | Unchanged |
| Rockefeller Capital Management L.P. | 3,166 | $3.00K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 2,447 | $3.00K | 0.00% | +716+41.4% | Added |
| Advisor Group Holdings, Inc. | 2,000 | $2.00K | 0.00% | 00.0% | Unchanged |
| First Manhattan Co | 1,000 | $1.00K | 0.00% | −1,000−50.0% | Reduced |
| TCI Wealth Advisors, Inc. | 500 | $1.00K | 0.00% | +200+66.7% | Added |
| China Universal Asset Management Co., Ltd. | 499 | $1.00K | 0.00% | +499 | New |
| Bank of America Corp | 584 | $0 | 0.00% | −128−18.0% | Reduced |
| Citigroup Inc | 410 | $0 | 0.00% | −181−30.6% | Reduced |
| Strategic Asset Management, LLC | 50 | $0 | 0.00% | 00.0% | Unchanged |
| IFP Advisors, Inc | 6,500 | – | – | −500−7.1% | Reduced |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −164,607−100.0% | Sold out |
| Cowen and Company, LLC | 0 | $0 | 0.00% | −124,590−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −106,408−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −18,261−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −14,531−100.0% | Sold out |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −1,136−100.0% | Sold out |